Variations in UK screening for Down's syndrome:
This article was originally published in Clinica
There are wide variations in the methodology and markers used for antenatal screening in the UK for Down's syndrome, says a new UK study in the October 9 edition of The Lancet. The survey shows that antenatal screening with serum or ultrasound markers has increased over the past decade. However, the most common method offered by health authorities - the double test, AFP and total or free b-hCG - is not the best, says the study.
You may also be interested in...
After urging the US Congress to act on updating Medicare Part D, the Association for Accessible Medicines has welcomed the decision to update Part D by the Centers for Medicare & Medicaid Services of the US Department of Health and Human Services.
Dr Reddy’s signals a sharp step up in ambitions at home, propelled by building leadership in 10 therapy segments and an “India-first” approach for specialty products. Uptick in the China business and the potential launch of a Russia-partnered COVID-19 vaccine were other aspects of the business discussed at JPM.
“You can’t just live off the brand equity anymore,” warned J&J's Consumer Health's Minoj Raghunandanan during the ‘Advancing Trust in the Self-Care Industry’ webinar co-hosted by the Global Self-Care Federation and HBW Insight. “You’ve got to continue to build that trust between consumers and products day-in day-out.”